Dx-Rx Institute ApS: Financial statements 2022
CVR: 38196537
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Dx-Rx Institute ApS (CVR 38196537) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -16,424 and a net result of DKK -16,470 compared with DKK 2,338 the year before. Equity in the 2022 report amounted to DKK 53,165. The solvency ratio was 89.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -16,424
- Profit/Loss
- DKK -16,470
- Equity
- DKK 53,165
- Total Assets
- DKK 59,357
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -16K | -16K | 53K | 1 |
| 2021 | - | 3K | 2K | 70K | 1 |
| 2020 | - | 23K | 18K | 67K | 0 |
| 2019 | - | 5K | 4K | 50K | 0 |
| 2018 | - | -13K | -10K | 46K | 0 |
Official annual report
Keep an eye on Dx-Rx Institute ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of October 18, 2022, Jan Trøst Jørgensen is registered as liquidator of Dx-Rx Institute ApS.
As of October 18, 2022, Jan Trøst Jørgensen has stepped down as director of Dx-Rx Institute ApS.
On October 18, 2022, Dx-Rx Institute ApS entered liquidation.
Dx-Rx Institute ApS has published its annual report for 2021. Gross profit came to DKK 3,099, and the net result was DKK 2,338.
About Dx-Rx Institute ApS
Dx-Rx Institute ApS was a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2016. The company has been dissolved on 30 May 2023. The company was registered under the industry Anden teknisk rådgivning. According to the 2022 annual report, the company had an average of 1 employee. In 2022, the company reported a gross profit of DKK -16,424 and a net result of DKK -16,470 compared with DKK 2,338 the year before. Equity in the 2022 report amounted to DKK 53,165.
